OPTION AGREEMENTOption Agreement • October 14th, 2022 • Brooklyn ImmunoTherapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 14th, 2022 Company Industry JurisdictionThis Option Agreement (“Agreement”) is made and entered into as of October 8, 2022 (the “Effective Date”), by and between Exacis Biotherapeutics, Inc., a corporation organized and existing under the laws of Delaware (“Rights Holder”), and Brooklyn ImmunoTherapeutics, Inc. (“Company”). Company and Rights Holder each may be referred to herein individually as a “Party” or collectively as the “Parties.”